Search Results - "Samara‐Kuko, Ermira"
-
1
Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates
Published in Nature genetics (01-06-2009)“…Zsuzsanna Izsvák and colleagues report the generation of a hyperactive version of the Sleeping Beauty transposase that supports efficient and stable gene…”
Get full text
Journal Article -
2
Hepatocyte‐targeted expression by integrase‐defective lentiviral vectors induces antigen‐specific tolerance in mice with low genotoxic risk
Published in Hepatology (Baltimore, Md.) (01-05-2011)“…Lentiviral vectors are attractive tools for liver‐directed gene therapy because of their capacity for stable gene expression and the lack of preexisting…”
Get full text
Journal Article -
3
Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons
Published in Molecular therapy. Nucleic acids (06-03-2020)“…We established a semi-high-throughput in vivo screening platform using hyperactive piggyBac (hyPB) transposons (designated as PB-miR) to identify microRNAs…”
Get full text
Journal Article -
4
Novel Hyperactive Transposons for Genetic Modification of Induced Pluripotent and Adult Stem Cells: A Nonviral Paradigm for Coaxed Differentiation
Published in Stem cells (Dayton, Ohio) (01-10-2010)“…Adult stem cells and induced pluripotent stem cells (iPS) hold great promise for regenerative medicine. The development of robust nonviral approaches for stem…”
Get full text
Journal Article -
5
UNIVERSAL ALLOGENEIC CAR T CELLS ENGINEERED WITH SLEEPING BEAUTY TRANSPOSONS AND CRISPR/CAS9 FOR CANCER IMMUNOTHERAPY
Published in Molecular therapy (05-10-2022)“…Allogeneic CD19-specific chimeric antigen receptor (CAR) T cells with inactivated donor T cell receptor (TCR) expression can be used as an ‘off-the-shelf’…”
Get full text
Journal Article -
6
Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9
Published in Molecular therapy (02-05-2018)“…In vivo tissue-specific genome editing at the desired loci is still a challenge. Here, we report that AAV9-delivery of truncated guide RNAs (gRNAs) and Cas9…”
Get full text
Journal Article -
7
Gene therapy for hemophilia B using CB 2679d-GT: a novel factor IX variant with higher potency than factor IX Padua
Published in Blood (27-05-2021)“…Sustained expression of therapeutic factor IX (FIX) levels has been achieved after adeno-associated viral (AAV) vector-based gene therapy in patients with…”
Get full text
Journal Article -
8
piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts
Published in Nucleic acids research (29-01-2016)“…Duchenne muscular dystrophy (DMD) is a genetic neuromuscular disorder caused by the absence of dystrophin. We developed a novel gene therapy approach based on…”
Get full text
Journal Article -
9
Genome-wide Computational Analysis Reveals Cardiomyocyte-specific Transcriptional Cis-regulatory Motifs That Enable Efficient Cardiac Gene Therapy
Published in Molecular therapy (01-01-2015)“…Gene therapy is a promising emerging therapeutic modality for the treatment of cardiovascular diseases and hereditary diseases that afflict the heart. Hence,…”
Get full text
Journal Article -
10
Liver-Specific Transcriptional Modules Identified by Genome-Wide In Silico Analysis Enable Efficient Gene Therapy in Mice and Non-Human Primates
Published in Molecular therapy (01-09-2014)“…The robustness and safety of liver-directed gene therapy can be substantially improved by enhancing expression of the therapeutic transgene in the liver. To…”
Get full text
Journal Article -
11
120. Efficient In Vivo Liver-Directed Gene Editing Using CRISPR/Cas9
Published in Molecular therapy (01-05-2016)Get full text
Journal Article -
12